Ishak Waguih William, Edwards Gabriel, Herrera Nathalie, Lin Tiffany, Hren Kathryn, Peterson Michael, Ngor Ashley, Liu Angela, Kimchi Asher, Spiegel Brennan, Hedrick Rebecca, Chernoff Robert, Diniz Marcio, Mirocha James, Manoukian Vicki, Ong Michael, Harold John, Danovitch Itai, Hamilton Michele
Drs. IsHak, Edwards, Herrera, Lin, Spiegel, Hedrick, Chernoff, Diniz, Danovitch; Mr. Mirocha and Mr. Peterson; and Ms. Hren, Ms. Nigor, Ms. Liu, and Ms. Manoukian and are with the Department of Psychiatry and Behavioral Neurosciences, Cedars-Sinai Medical Center in Los Angeles, California.
Drs. Ishak, Spiegel, and Ong are with the David Geffen School of Medicine at UCLA in Los Angeles, California.
Innov Clin Neurosci. 2020 Apr 1;17(4-6):27-38.
: This paper sought to identify the instruments used to measure depression in heart failure (HF) and elucidate the impact of treatment interventions on depression in HF. The Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines were followed. Studies published from 1988 to 2018 covering depression and HF were identified through the review of the PubMed and PsycINFO databases using the keywords: "depres*" AND "heart failure." Two authors independently conducted a focused analysis, identifying 27 studies that met the specific selection criteria and passed the study quality checks. Patient-reported questionnaires were more commonly adopted than clinician-rated questionnaires, including the Beck Depression Inventory, the Patient Health Questionnaire (PHQ-9), and the Hospital Anxiety and Depression Scale. Six common interventions were observed: antidepressant medications, collaborative care, psychotherapy, exercise, education, and other nonpharmacological interventions. Except for paroxetine, selective serotonin reuptake inhibitors failed to show a significant difference from placebo. However, the collaborative care model including the use of antidepressants showed a significant decrease in PHQ-9 score after one year. All of the psychotherapy studies included a variation of cognitive behavioral therapy and patients showed significant improvements. The evidence was mixed for exercise, education, and other nonpharmacological interventions. This study suggests which types of interventions are more effective in addressing depression in heart failure patients.
本文旨在确定用于测量心力衰竭(HF)患者抑郁症状的工具,并阐明治疗干预措施对HF患者抑郁症状的影响。本研究遵循系统评价和荟萃分析的首选报告项目指南。通过使用关键词“depres*”和“heart failure”检索PubMed和PsycINFO数据库,确定了1988年至2018年发表的涵盖抑郁和HF的研究。两位作者独立进行了重点分析,确定了27项符合特定选择标准并通过研究质量检查的研究。患者报告问卷比临床医生评定问卷更常用,包括贝克抑郁量表、患者健康问卷(PHQ-9)和医院焦虑抑郁量表。观察到六种常见的干预措施:抗抑郁药物、协作护理、心理治疗、运动、教育和其他非药物干预措施。除帕罗西汀外,选择性5-羟色胺再摄取抑制剂与安慰剂相比未显示出显著差异。然而,包括使用抗抑郁药在内的协作护理模式在一年后PHQ-9评分显著降低。所有心理治疗研究均包括认知行为疗法的变体,患者显示出显著改善。运动、教育和其他非药物干预措施的证据参差不齐。本研究表明了哪些类型的干预措施在解决心力衰竭患者抑郁症状方面更有效。